Your gift is 100% tax deductible
Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.?
Chat live online
Select the?Live?Chat button at the bottom of the page?
Call us at?1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat.?We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
There's plenty of evidence that routine screening for colorectal cancer can find cancer at an earlier stage and in some cases even prevent it by removing precancerous polyps during colonoscopy.?
Studies also show that the strongest and most consistent reason people follow through on the screening guideline is because their doctor recommended it.
Yet, screening prevalence for colorectal cancer in the United States remains low. The question is: Are doctors talking about options for screening to their patients who have an average risk of developing colorectal cancer?
Jordan Baeker Bispo, PhD, MPH, principal scientist in P站视频 Cancer Disparity Research, led a study published as a letter in the , that used data from the 2019 and 2021 National Health Interview Survey. She and her colleagues focused on adults ages 50 to 75 who said they were not up to date with colorectal cancer screening and had a wellness visit in the past year. They found that only about 1 of 4 of these adults reported that their doctor had recommended colorectal cancer screening. That means 3 out of 4 said their doctor didn't suggest cancer screening.
The researchers found that marginalized racial/ethnic groups were more likely to self-report that in the past 2 years, their doctor had not recommended colorectal cancer screening. People with a limited education or health insurance had similar reports.
Although clinicians overwhelmingly report that they recommend colorectal cancer screening to average-risk patients, limited data exist on the consistency with which they do so, and the low patient-reported prevalence in this study is alarming. The findings highlight a major communication gap about colorectal cancer prevention in the clinical setting.
Jordan Baeker Bispo, PhD, MPH
Cancer Disparity Research, Principal Scientist
Surveillance & Health Equity Science, P站视频
Other P站视频 researchers who contributed to this publication were: Priti Bandi, PhD, Ahmedin Jemal, DVM, PhD, and Farhad Islami, MD, PhD.
This report highlights the need for concerted efforts to improve screening prevalence by investing in education at the level of patients, health providers, health systems, and the general population.
To advance progress toward national screening goals, evidence-based interventions might be particularly helpful among racial/ethnic and socioeconomic subgroups shown to have the lowest prevalence of screening. Some strategies may include health systems investing in:
?
? ??? ?
We fund research breakthroughs that save lives. Your year-end gift helps find new treatments for cancer.